Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajime Sano

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[Treatment of rheumatic diseases: current status and future prospective. Topics: I. Steroid/nonsteroidal anti-inflammatory drugs; 2. Nonsteroidal anti-inflammatory drugs (COX-2 selective inhibitors)]Hajime Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Selective COX-2 inhibitors for therapy of rheumatoid arthritis]Hajime Sano
Ryumachi. [Rheumatism]|August 9, 2002
[A new mechanism of COX-2 in inflammation]Hajime Sano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 30, 2007
[Diagnosis and therapy for polymyalgia rheumatica]Hajime Sano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 28, 2011
[II. Autoimmune disease: 2. Renal disturbance in rheumatoid arthritis]Naoto Azuma, Hajime Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Abnormalities in electrocardiogram of patients with rheumatoid arthritis]Naoaki Hashimoto, Hajime Sano
Leukemia & Lymphoma|September 4, 2003
Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levelsTsuyoshi Iwasaki, Hajime Sano
Leukemia & Lymphoma|September 4, 2003
Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levelsTsuyoshi Iwasaki, Hajime Sano
Journal of Clinical Medicine|July 6, 2017
T Helper 17 Cells in Primary Sjögren's SyndromeKiyoshi Matsui, Hajime Sano
Inflammation and Regeneration|April 17, 2018
Deterioration in saliva quality in patients with Sjögren's syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestationsNaoto Azuma, Yoshinori Katada, Hajime Sano
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[Treatment of rheumatic diseases: current status and future prospective. Topics: I. Steroid/nonsteroidal anti-inflammatory drugs; 2. Nonsteroidal anti-inflammatory drugs (COX-2 selective inhibitors)]Hajime Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Selective COX-2 inhibitors for therapy of rheumatoid arthritis]Hajime Sano
Ryumachi. [Rheumatism]|August 9, 2002
[A new mechanism of COX-2 in inflammation]Hajime Sano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 30, 2007
[Diagnosis and therapy for polymyalgia rheumatica]Hajime Sano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 28, 2011
[II. Autoimmune disease: 2. Renal disturbance in rheumatoid arthritis]Naoto Azuma, Hajime Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Abnormalities in electrocardiogram of patients with rheumatoid arthritis]Naoaki Hashimoto, Hajime Sano
Leukemia & Lymphoma|September 4, 2003
Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levelsTsuyoshi Iwasaki, Hajime Sano
Leukemia & Lymphoma|September 4, 2003
Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levelsTsuyoshi Iwasaki, Hajime Sano
Journal of Clinical Medicine|July 6, 2017
T Helper 17 Cells in Primary Sjögren's SyndromeKiyoshi Matsui, Hajime Sano
Inflammation and Regeneration|April 17, 2018
Deterioration in saliva quality in patients with Sjögren's syndrome: impact of decrease in salivary epidermal growth factor on the severity of intraoral manifestationsNaoto Azuma, Yoshinori Katada, Hajime Sano
Pageof 17